SEC Company Response from IGC Pharma, Inc. (IGC) (CIK 0001326205) (IGC) — May 9, 2018
IGC Pharma, Inc. (IGC) (CIK 0001326205)
Date: May 9, 2018 · CIK: 0001326205 · Accession: 0001185185-18-000814
AI Filing Summary & Sentiment
File numbers found in text: 333-224082
Show Raw Text
CORRESP
1
filename1.htm
May 9, 2018
VIA EMAIL AND EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Heather Percival, Esq.,
Division of Corporation Finance
Re:
India Globalization Capital, Inc.
Registration Statement on Form S-3 (No. 333-224082)
Ladies and Gentlemen:
On behalf of India Globalization Capital, Inc. (the “Company”), we enclose the Company’s request for acceleration of the above-referenced Registration Statement to 9:30 a.m., Eastern time, on Friday, May 11, 2018, or as soon as possible thereafter.
Please advise the undersigned of the effectiveness of the Registration Statement.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc:
Mr. Ram Mukunda
Ms. Claudia Grimaldi
India Globalization Capital, Inc.
4336 Montgomery Avenue
Bethesda, Maryland 20814
May 9, 2018
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Heather Percival, Esq.,
Division of Corporation Finance
Re:
India Globalization Capital, Inc.
Registration Statement on Form S-3 (No. 333-224082)
Ladies and Gentlemen:
India Globalization Capital, Inc. hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 9:30 a.m., Eastern time, on Friday, May 11, 2018, or as soon as possible thereafter.
Very truly yours,
INDIA GLOBALIZATION CAPITAL, INC.
By:
/s/ Ram Mukunda
Ram Mukunda
President and Chief Executive Officer